List of Studies ( Metabolite:Ciclopirox)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003880 | AN006373 | Untargeted metabolome analysis of control and disease intervertebral disc tissue | Tissue | Human | Bone disease | Ganga Orthopaedic Research and Education Foundation | LC-MS |
| ST003279 | AN005371 | Metabolomic analysis of Axon Regeneration in Xenopus laevis Tectum | Eye tissue | Frog | Eye disease | University of Miami | LC-MS |
| ST003278 | AN005369 | Metabolomic analysis of Axon Regeneration in Xenopus laevis Retina | Eye tissue | Frog | Eye disease | University of Miami | LC-MS |
| ST003002 | AN004931 | The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) | Feces | Human | Sarcopenia | Chinese University of Hong Kong | GC-MS/LC-MS |
| ST002977 | AN004887 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | LC-MS | |
| ST002977 | AN004889 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | LC-MS | |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |